Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.

about

What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

P2860

Q40550507-1ED8A5D4-62D8-4B22-8889-E008FBDF7B7B

P2860

Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.

Item

http://www.wikidata.org/entity/Q38934400

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Prescribing Ceftolozane/Tazoba ...... tatus and Future Implications.

@en

type

Item

label

Prescribing Ceftolozane/Tazoba ...... tatus and Future Implications.

@en

prefLabel

Prescribing Ceftolozane/Tazoba ...... tatus and Future Implications.

@en

P1476

Prescribing Ceftolozane/Tazoba ...... tatus and Future Implications.

@en

P2093

Alice J Hsu

http://www.w3.org/2001/XMLSchema#string

Pranita D Tamma

http://www.w3.org/2001/XMLSchema#string

Seetha M Tamma

http://www.w3.org/2001/XMLSchema#string

P2860

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

Updated functional classification of beta-lactamases

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)

Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam.

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.

In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice.

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa

P2888

s40272-015-0157-x

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-015-0157-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043315516

http://www.w3.org/2001/XMLSchema#string

P698

26645401

http://www.w3.org/2001/XMLSchema#string

Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.

about

P2860

P2860

Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698